Empowered Funds, LLC Pacira Bio Sciences, Inc. Call Options Transaction History
Empowered Funds, LLC
- $8.46 Billion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|---|---|---|---|---|
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
Others Institutions Holding PCRX
# of Institutions
257Shares Held
51.4MCall Options Held
289KPut Options Held
130K-
Black Rock Inc. New York, NY8.01MShares$209 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.41MShares$141 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.4MShares$62.5 Million0.08% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY2.25MShares$58.7 Million0.04% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.15MShares$56.1 Million0.01% of portfolio
About Pacira BioSciences, Inc.
- Ticker PCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,824,200
- Market Cap $1.19B
- Description
- Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...